Abstract

BackgroundAmong breast cancer (BC) patients the outcomes of anticancer therapy vary dramatically due to the highly heterogeneous molecular characteristics of BC. Therefore, an extended panel of BC cell lines are required for in vitro and in vivo studies to find out new characteristic of carcinogenesis and metastasis. The purpose of this study was to develop patient-derived BC cell cultures and metastatic tumor models representing a tool for personal therapy and translational research.MethodsBreast cancer cells were prepared by optimizing technique from tumor samples. We used real-time RT-PCR, flow cytometry, western blotting, cytotoxicity assay, karyotyping and fluorescent and electron microscopy analyses to characterize the established cell lines. BC xenografts in scid mice were used for in vivo tumorigenicity studies.ResultsThe technique of preparing primary cells was optimized and this resulted in a high output of viable and active proliferated cells of nine patient-derived breast cancer cell lines and one breast non-malignant cell line. High E-cadherine and EpCAM expression correlated positively with epithelial phenotype while high expression of N-cadherine and Vimentin were shown in cells with mesenchymal phenotype. All mesenchymal-like cell lines were high HER3-positive—up to 90%. More interesting than that, is that two cell lines under specific culturing conditions (pulsed hypoxia and conditioned media) progressively transformed from mesenchymal to epithelial phenotypes displaying the expression of respective molecular markers proving that the mesenchymal-to-epithelial transition occurred. Becoming epithelial, these cells have lost HER3 and decreased HER2 membrane receptors. Three of the established epithelial cancer cell lines were tumorigenic in SCID mice and the generated tumors exhibited lobules-like structures. Ultrastructure analysis revealed low-differentiate phenotype of tumorigenic cell lines. These cells were in near-triploid range with multiple chromosome rearrangements. Tumorigenic BrCCh4e cells, originated from the patient of four-course chemotherapy, initiated metastasis when they were grafted subcutaneous with colonization of mediastinum lymph nodes.ConclusionsThe developed BC cells metastasizing to mediastinum lymph nodes are a relevant model for downstream applications. Moreover, our findings demonstrate that pulsed hypoxia induces transformation of primary fibroblastoid breast cancer cells to epithelial-like cells and both of these cultures—induced and original—don’t show tumor initiating capacity.

Highlights

  • Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramatically due to the highly heterogeneous molecular characteristics of BC

  • As opposed to migrated metastatic tumor cells in humans, cells in carcinoma metastasis sites lack a mesenchymal phenotype and present epithelial morphology [23]. From this point of view, “pulsed hypoxia” can mimic the conditions that metastatic tumor cells undergo during their travelling in the human organism with the implantation in a terminal site

  • We agree with Xie, who declares that in some breast cancer cell lines only the inherent ability of cancerous cells is responsible for tumor-initiating capacity, not epithelial–mesenchymal transition (EMT) or mesenchymal-to-epithelial transition (MET) status [7]

Read more

Summary

Introduction

Among breast cancer (BC) patients the outcomes of anticancer therapy vary dramatically due to the highly heterogeneous molecular characteristics of BC. A vast number of immortalized human breast cancer cell lines being injected into immunocompromised animals induce the growth of tumor nodes, only a few of them induce metastases [2, 3] Such limitation of cultured cancer cells becomes complicated in the investigation of metastasis and metastasis-associated cellular transformation in vivo as well as the anti-metastatic potential of new therapeutics. Patient-specific cell lines allow us to realize personal therapy as well as to find out new characteristic of carcinogenesis and metastasis This approach can give the direct information of the tumor cell’s sensitivity to defined drugs in contrast to the prediction methods based on genome-wide genotyping data [4]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call